MENU
+Compare
CATX
Stock ticker: ASE
AS OF
Jul 3 closing price
Price
$3.68
Change
+$0.29 (+8.55%)
Capitalization
751.25M

CATX Perspective Therapeutics Forecast, Technical & Fundamental Analysis

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CATX with price predictions
Jul 03, 2025

CATX in downward trend: price may decline as a result of having broken its higher Bollinger Band on June 23, 2025

CATX broke above its upper Bollinger Band on June 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In of the 37 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CATX moved out of overbought territory on June 24, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for CATX turned negative on June 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CATX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on July 03, 2025. You may want to consider a long position or call options on CATX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CATX advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 173 cases where CATX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.990) is normal, around the industry mean (24.348). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (70.423) is also within normal values, averaging (42.660).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CATX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CATX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CATX is expected to report earnings to rise 17.16% to -29 cents per share on August 08

Perspective Therapeutics CATX Stock Earnings Reports
Q2'25
Est.
$-0.29
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.30
Q3'24
Est.
$-0.21
Q2'24
Missed
by $0.16
The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -31 cents. With 511.20K shares outstanding, the current market capitalization sits at 751.25M.
A.I. Advisor
published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIOPX51.280.82
+1.63%
Baron Opportunity Retail
ITHIX44.410.34
+0.77%
Hartford Capital Appreciation I
SPVZX25.980.18
+0.70%
PGIM Quant Solutions Mid-Cap Val Z
GCLSX24.660.15
+0.61%
Goldman Sachs Large Cp Val Insghts Svc
NSFFX11.910.02
+0.17%
Natixis Target Retirement 2030 N

CATX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+8.55%
STRR - CATX
88%
Closely correlated
+0.51%
SHC - CATX
34%
Loosely correlated
+0.90%
MTD - CATX
29%
Poorly correlated
+0.28%
OFIX - CATX
28%
Poorly correlated
+0.54%
DHR - CATX
28%
Poorly correlated
+0.35%
More

Groups containing CATX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+8.55%
CATX
(2 stocks)
92%
Closely correlated
+4.53%